Literature DB >> 4345237

Potentiation of phenothiazines by -methyltyrosine in treatment of chronic schizophrenia.

A Carlsson, T Persson, B E Roos, J Wålinder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4345237     DOI： 10.1007/bf01260898

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


× No keyword cloud information.
  7 in total

1.  A simple and reliable subclassification of chronic schizophrenia.

Authors:  J K WING
Journal:  J Ment Sci       Date:  1961-09

2.  The measurement of behaviour in chronic schizophrenia.

Authors:  J K Wing
Journal:  Acta Psychiatr Scand       Date:  1960       Impact factor: 6.392

3.  Behavioral effects of haloperidol after tyrosine hydroxylase inhibition.

Authors:  S Ahlenius; J Engel
Journal:  Eur J Pharmacol       Date:  1971-07       Impact factor: 4.432

Review 4.  Adrenergic mechanisms.

Authors:  N E Andén; A Carlsson; J Häggendal
Journal:  Annu Rev Pharmacol       Date:  1969       Impact factor: 13.820

5.  Metabolism of alpha-methyltyrosine in man: relationship to its potency as an inhibitor of catecholamine biosynthesis.

Authors:  K Engelman; E Jéquier; S Udenfriend; A Sjoerdsma
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

6.  Biochemical and pharmacologic effects of alpha-methyltyrosine in man.

Authors:  K Engelman; D Horwitz; E Jéquier; A Sjoerdsma
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

7.  Alpha-methyl-p-tyrosine (AMT) in schizophrenia.

Authors:  S Gershon; L J Hekimian; A Floyd; L E Hollister
Journal:  Psychopharmacologia       Date:  1967
  7 in total
  14 in total

1.  Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: implications for the treatment of Tardive dyskinesia.

Authors:  B K Koe
Journal:  Experientia       Date:  1975-06-15

2.  Potentiation by lithium of the haloperidol-induced behavioural suppression.

Authors:  S Ahlenius; J Engel
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

3.  Effects of multiple pretreatment with apomorphine and amphetamine on amphetamine-induced locomotor activity and its inhibition by apomorphine.

Authors:  W H Riffee; R E Wilcox
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Normalization by antipsychotic drugs of biochemically induced abnormal behavior in rats.

Authors:  S Ahlenius; J Engel
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

5.  Further studies on the mechanism of antipsychotic action: potentiation by alpha-methyltyrosine of thioridazine effects in chronic schizophrenics.

Authors:  A Carlsson; B E Roos; J Wålinder; A Skott
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

Review 6.  [Biochemical effects of psychotropic drugs in central nervous system (author's transl)].

Authors:  M Karobath
Journal:  Klin Wochenschr       Date:  1979-06-15

Review 7.  Effect of apomorphine on schizophrenic symptoms.

Authors:  R C Smith; C Tamminga; J M Davis
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

8.  Effects of the local application of 3-PPP and sulpiride enantiomers into the nucleus accumbens or into the ventral tegmental area on rat locomotor activity: evidence for the functional importance of somatodendritic autoreceptors.

Authors:  S Ahlenius
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

9.  Antipsychotic treatment with alpha-methyltyrosine in combination with thioridazine: prolactin response and interaction with dopaminergic precursor pools.

Authors:  M Larsson; R Ohman; L Wallin; J Wålinder; A Carlsson
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

10.  Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function.

Authors:  A Wolkin; E Duncan; M Sanfilipo; S Wieland; T B Cooper; J Rotrosen
Journal:  J Neural Transm Gen Sect       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.